Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label...

por Alderson, Derek, Cunningham, David, Nankivell, Matthew, Blazeby, Jane M, Griffin, S Michael, Crellin, Adrian, Grabsch, Heike I, Langer, Rupert, Pritchard, Susan, Okines, Alicia, Krysztopik, Richard, Coxon, Fareeda, Thompson, Joyce, Falk, Stephen, Robb, Clare, Stenning, Sally, Langley, Ruth E
Publicado 2017